Author

M. Zhang

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Triglyceride–glucose muscle-loss index and all-cause and cardiovascular mortality in cardiovascular-kidney-metabolic syndrome stages 0–3: NHANES findings with validation in CHARLS

A composite triglyceride–glucose–muscle loss index (TyG-MLI), integrating insulin resistance (TyG) and a muscle-related metabolic reserve signal (cystatin C/creatinine ratio), may improve risk stratification in cardiometabolic–kidney–metabolic (CKM) stages 0–3, but its prognostic value is unclear. To exami...

Z. Chen, Z. Chang, S. Zhang et al. · European Heart Journal · 0 citations

Open access Oct 2026

Obstructive sleep apnea, insulin resistance and long-term cardiovascular outcomes in acute coronary syndrome

Insulin resistance (IR) is a critical modifiable risk factor in acute coronary syndrome (ACS). Obstructive sleep apnea (OSA), prevalent in ACS, is associated with adverse outcomes and may also affect IR. We elucidated the relationship between IR and long-term cardiovascular outcomes in ACS patients with or withou...

F. Zhang, W. Hao, Y. Xing et al. · European Heart Journal · 0 citations

Open access Oct 2026

Predictive value of serial coronary CTA-derived fractional flow reserve in patients with coronary artery disease

The prognostic significance of longitudinal change in CCTA derived fractional flow reserve (CT-FFR) in patients with coronary artery disease (CAD) remains incompletely defined. We aim to investigate whether hemodynamic changes during serial CCTA examinations are associated with an increased risk of MACE. W...

M. Zhang, X. Kong, S. Zhang et al. · European Heart Journal · 0 citations